MyFinsight
Home
Blog
About
Contact
Download
Download image
Net loss
attributable to xencor, inc
-$128.916M
(-166.26%↓ Y/Y)
Net loss including
noncontrolling interest
-$128.916M
(-165.08%↓ Y/Y)
Loss before income
tax expense and...
-$128.636M
(-166.52%↓ Y/Y)
Income tax expense
$0.28M
(-23.71%↓ Y/Y)
Incyte Corporation
$2.936M
Alexion
Pharmaceuticals Inc
$1.48M
(-90.43%↓ Y/Y)
Operating loss
-$77.862M
(-80.31%↓ Y/Y)
Total other expense
-$50.774M
(-899.09%↓ Y/Y)
Collaborations, milestones, and
royalties
$4.516M
(-86.20%↓ Y/Y)
Interest income
$5.459M
(-27.58%↓ Y/Y)
Other, net
$0.396M
(1377.42%↑ Y/Y)
Total operating
expenses
$82.378M
(8.51%↑ Y/Y)
(losses) gains on equity
securities, net
-$51.929M
(-5618.49%↓ Y/Y)
Interest expense
$4.7M
(-45.76%↓ Y/Y)
Research and development
$64.669M
(10.40%↑ Y/Y)
General and
administrative
$17.709M
(2.15%↑ Y/Y)
Back
Back
Income Statement
source: myfinsight.com
Xencor Inc (XNCR)
Xencor Inc (XNCR)